Sonova Holding AG stock analysis
Sonova Holding AG (0QPY) Share Price & Analysis
0QPY Stock Chart & Stats
- Day’s Range
- CHF 285.00 - CHF 289.80
- 52-Week Range
- CHF 163.20 - CHF 293.80
- Previous Close
- CHF 289.20
- Volume
- N/A
- Average Volume (3M)
- 37.11K
- Market Cap
- CHF 16.55B
- Enterprise Value
- CHF 16.07B
- Total Cash (Recent Filing)
- CHF 677.70M
- Total Debt (Recent Filing)
- CHF 1.76B
- Price to Earnings (P/E)
- 34.7
- Beta
- 1.16
- Next Earnings
- May 18, 2027 (Est.)
- EPS Estimate
- 6.39
- Last Dividend Ex-Date
- Jun 19, 2026
- Dividend Yield
- 1.64%
Bulls Say, Bears Say
Bulls Say
Market Share Gains
Sustained double-digit wholesale growth and 11 consecutive quarters of share gains indicate that Sonova is expanding faster than competitors. Broader customer relationships, VA deliveries, and product launches are reinforcing distribution strength and supporting durable revenue growth.
Strong Margins And Cash Generation
High gross margins and sharply improved free cash flow demonstrate strong earnings quality and operating leverage. This financial profile gives Sonova resources to fund research, digital investments, retail expansion, and acquisitions while maintaining balance-sheet discipline.
Raised Growth Outlook
Raised sales and core EBIT guidance, together with a 5%-10% midterm sales growth target, signals management confidence in the portfolio and market position. Higher expected profit growth can support continued investment and strengthen execution over coming quarters.
Bears Say
Cochlear Implant Weakness
The cochlear implant business is a persistent execution weakness, with lower systems and upgrade sales compounded by China VBP and weaker U.S. demand. Underperformance can dilute group growth and requires successful innovation and commercialization to restore momentum.
Recent Annual Revenue Decline
The latest annual revenue decline and margin compression show that recent underlying momentum has been uneven despite the stronger first-half update. If this pattern persists, it could constrain operating leverage and make the raised outlook more dependent on successful execution.
Retail Efficiency And Customer Headwinds
Higher sales and marketing spending has not yet produced satisfactory retail conversion, while a major customer merger may reduce future sourcing. These issues could pressure retail returns and make channel growth less efficient over the next several quarters.
Sonova Holding AG News
0QPY FAQ
What was Sonova Holding AG’s price range in the past 12 months?
What is Sonova Holding AG’s market cap?
When is Sonova Holding AG’s upcoming earnings report date?
How were Sonova Holding AG’s earnings last quarter?
Is Sonova Holding AG overvalued?
Does Sonova Holding AG pay dividends?
What is Sonova Holding AG’s EPS estimate?
How many shares outstanding does Sonova Holding AG have?
What happened to Sonova Holding AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sonova Holding AG?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sonova Holding AG
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Eric Alain Bernard
- Employees
- 18,580
- Website
- www.sonova.com
- Address
- Laubisrutistrasse 28, Stäfa, ZH, 8712, CH
Sonova Holding AG (0QPY) Earnings & Revenues
0QPY Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Sonova reported broad-based sales growth, significant core EBIT and EPS expansion, higher cash generation and continued market share gains, while raising full-year sales and EBIT guidance. The main challenges were the 10% decline in cochlear implant sales, uncertainty around U.S. regulatory approval for Integro, lower reported EPS from discontinued operations, retail marketing efficiency and expected second-half normalization and customer-related headwinds.
View all GB:0QPY earnings summaries0QPY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 12 | 0 | 0 |














